🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A study to evaluate the effect of over- the- counter (OTC) lubricating eye ...
Status
Recruiting
Location
Andover Eye Associates
Start Date
2026-06-03
Trial ID
NCT07676084
To evaluate the efficacy of once daily dosing with SPARC's novel ophthalmic...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-06-10
Trial ID
NCT03927443
This randomized dose-ranging study will evaluate the safety, tolerability, ...
Status
Unknown
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01520116
The purpose of this study is to assess the ocular comfort and safety of olo...
Status
Completed
Location
Multiple Locations
Start Date
2011-04
Trial ID
NCT01326858
Summary: Purpose: To compare the safety and efficacy of eyelid treatment w...
Status
Completed
Location
Clínica de Oftalmología de Cali S.A
Start Date
2020-10-15
Trial ID
NCT06278584
Treatments Being Tested
The objective of this study is to evaluate tolerability, safety and efficac...
Status
Completed
Location
Dipartimento "Organi di Senso" Università La Sapienza- Policlinico Umberto I
Start Date
2015-06-26
Trial ID
NCT02507934
Treatments Being Tested
Qlaris Phase 2 clinical study investigating the safety, tolerability, and o...
Status
Completed
Location
Berkeley Eye Center
Start Date
2024-04-21
Trial ID
NCT06249152
Treatments Being Tested
This study will evaluate the safety and efficacy of SJP-0132 in Chinese Pat...
Status
Completed
Location
Beijing Hospital
Start Date
2024-12-30
Trial ID
NCT06717152
To evaluate the safety and efficacy of OTX-DP as a sustained release drug (...
Status
Completed
Location
Chicago Cornea Consultants, Ltd.
Start Date
2012-10
Trial ID
NCT01666210
Treatments Being Tested
Compare the corneal penetration of levofloxacin 1.5% and moxifloxacin 0.5% ...
Status
Terminated
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT00764582
Treatments Being Tested